Giant Papillary Conjunctivitis

Contact Lens–Related (Most Common)

• Soft hydrogel contact lenses: Historically the most common cause; high water-content hydrogel lenses accumulate surface deposits (proteins, lipids, mucins) most readily, providing a rich antigenic substrate for immune sensitisation
• Silicone hydrogel contact lenses: Although silicone hydrogel materials have superior oxygen permeability, they carry significant surface hydrophobicity and attract lipid deposits; GPC incidence is similar to or marginally lower than conventional hydrogels depending on lens design and replacement schedule
• Rigid gas permeable (RGP) lenses: Lower incidence than soft lenses due to reduced protein denaturation and greater ease of cleaning; however, RGP-associated GPC has been documented, typically in patients with deposits on the lens posterior surface
• Orthokeratology lenses: Worn overnight; prolonged mechanical contact with the superior tarsal conjunctiva; reported as a less common but recognised cause
• Lens care solution preservatives: Thimerosal (now largely discontinued) and benzalkonium chloride (BAK) in multipurpose solutions act as haptens, sensitising the conjunctival epithelium and augmenting the immune response to lens surface antigens

Non–Contact Lens Causes

• Ocular prostheses (artificial eyes): Poorly polished, ill-fitting, or infrequently cleaned acrylic prostheses produce repetitive mechanical abrasion of the superior tarsal conjunctiva; one of the original descriptions of GPC pre-dates contact lenses
• Exposed or protruding ocular sutures: Permanent sutures from corneal, scleral, or strabismus surgery that erode through the conjunctival surface and repetitively abrade the upper tarsal plate; a specific and fully reversible form upon suture removal
• Filtering blebs (post-trabeculectomy): Elevated blebs with exposed conjunctival sutures or exuberant bleb growth can mechanically irritate the superior tarsal conjunctiva
• Extruding scleral buckles: Migration of buckle material to the conjunctival surface in retinal detachment surgery; triggers localised tarsal inflammation
• Limbal dermoids and epibulbar lesions: Raised lesions at or near the limbus contacting the upper tarsal surface during blinking
• Exposed haptics of intraocular lenses (IOL): Rare reports of extruded IOL haptics reaching the conjunctival surface

Antigenic Triggers on Contact Lens Surfaces

• Denatured tear proteins: Lysozyme, lactoferrin, albumin, and IgA undergo conformational change when adsorbed to contact lens polymer surfaces, exposing cryptic epitopes that trigger immune responses
• Lipid deposits: Cholesterol esters, fatty acids, and phospholipids accumulate on lens surfaces — particularly silicone hydrogels — and reduce lens wettability while contributing antigenic material
• Mucin balls: Spherical mucin aggregates trapped beneath silicone hydrogel lenses during overnight wear; associated with mechanical tarsal trauma
• Microbial biofilm: Bacteria (Pseudomonas, Staphylococcus) colonising lens surfaces add additional antigenic and inflammatory stimuli

Dual Mechanism: Mechanical Trauma and Immunological Sensitisation

GPC results from the synergistic interaction of two pathways. Neither mechanical trauma alone nor immune sensitisation alone is sufficient to produce the full clinical picture; both contribute to the characteristic papillary hypertrophy of the upper tarsal conjunctiva.

1. Mechanical phase: Each blink subjects the upper tarsal conjunctiva to repetitive shear stress from the lens edge and posterior surface. Micro-trauma to the conjunctival epithelium disrupts tight junctions, increasing epithelial permeability to deposited antigens. Goblet cell loss and mucin disruption further compromise the protective mucosal barrier
2. Antigen deposition and sensitisation: Denatured tear proteins adsorbed onto the lens surface are presented to subepithelial dendritic cells and macrophages. In susceptible individuals, this drives Th2-polarised immune responses with IgE production (type I hypersensitivity) directed against protein neo-antigens. Thimerosal and lens polymer components may act as haptens, augmenting sensitisation
3. Mast cell activation (early phase): Allergen-specific IgE bound to FcεRI receptors on conjunctival mast cells is cross-linked upon re-exposure, triggering degranulation. Released histamine, tryptase, prostaglandin D2, and leukotrienes produce the immediate symptoms of itching and mucoid discharge
4. Eosinophil recruitment (late phase): IL-5 and eotaxin produced during the early phase recruit eosinophils into the conjunctival stroma. Eosinophil granule proteins (major basic protein, eosinophil cationic protein) further damage the conjunctival epithelium and contribute to subepithelial collagen remodelling
5. T-cell–mediated response (type IV): CD4+ T-helper cells, sensitised to lens surface antigens, orchestrate a delayed hypersensitivity response contributing to the chronic, persistent nature of GPC. Cytokines including IL-4, IL-13, and IFN-γ drive mast cell hyperplasia and subepithelial fibroblast activation
6. Papilla formation: Sustained inflammatory cell infiltration (mast cells, eosinophils, basophils, lymphocytes, plasma cells) accumulates in the conjunctival substantia propria. Inflammatory mediators stimulate fibroblast proliferation and collagen deposition. Repeated cycles of injury and repair produce progressive hypertrophy of the subepithelial connective tissue mounds, forming the macroscopically visible papillae. Each papilla contains a central fibrovascular core — a dilated stromal vessel surrounded by an inflammatory cell infiltrate — capped by hyperplastic conjunctival epithelium

Histopathology

Conjunctival biopsies in GPC demonstrate: (1) epithelial hyperplasia with increased goblet cell density in early stages, transitioning to goblet cell depletion in established disease; (2) thickened basement membrane; (3) subepithelial accumulation of mast cells, eosinophils, basophils, lymphocytes, and plasma cells; (4) increased subepithelial collagen deposition (fibrosis); and (5) dilated fibrovascular papillary cores. Eosinophil counts correlate with disease severity. The histological profile distinguishes GPC from purely mechanical papillary hypertrophy (where eosinophils are absent) and from vernal keratoconjunctivitis (where the eosinophilic and fibrotic changes are more severe and corneal involvement is prevalent).

By Aetiology

• Contact lens–induced GPC (CL-GPC): The predominant form; subdivided by lens type (soft hydrogel, silicone hydrogel, rigid gas-permeable, orthokeratology)
• Prosthesis-induced GPC: Associated with ocular prostheses; often more severe and slower to respond to treatment given continuous surface contact
• Suture-induced GPC: Linked to exposed or broken sutures; fully reversible on suture removal; rapid resolution distinguishes it from other forms
• Idiopathic GPC: Rare cases without identifiable mechanical or antigenic trigger; immune mechanism predominates; requires exclusion of occult foreign material

Allansmith Grading System (Contact Lens–Induced GPC)

By Papillary Morphology

• Papillary (non-giant, <1 mm): Early or mild reaction; indistinguishable clinically from non-specific papillary conjunctivitis without full clinical context
• Giant papillary (>1 mm): Defining feature; uniform distribution across the superior tarsal plate; cobblestone appearance; contains central dilated vascular core
• Apical stippling: Fluorescein or rose bengal staining of the papilla tips indicates active epithelial damage from the lens surface; marker of advanced disease

Lens-Related Risk Factors

• Extended or continuous wear: Sleeping in contact lenses dramatically increases antigen accumulation and mechanical trauma; extended wear wearers have a 4–10× higher incidence of GPC compared to daily wear
• Infrequent lens replacement: Monthly and quarterly replacement schedules allow progressive protein and lipid deposition; daily disposable lenses have the lowest GPC incidence of all soft lens types, as each fresh lens presents a clean surface
• Poor lens cleaning compliance: Inadequate rub-and-rinse technique fails to remove surface deposits; no-rub multipurpose solution regimens are associated with higher deposit accumulation than rub-and-rinse protocols
• High water-content conventional hydrogel lenses: Greater protein uptake capacity compared to low water-content or silicone hydrogel materials; the material and surface treatment of the lens determine deposit propensity
• Thimerosal-preserved lens care solutions: Now largely withdrawn but historically a major sensitising agent; current BAK-containing solutions can contribute to sensitisation
• Lens edge design: Lenses with thicker, rougher, or irregular edges generate greater mechanical shear on the superior tarsal conjunctiva with each blink; edge geometry is a modifiable risk factor
• Ill-fitting lenses: Excessive lens movement or decentration on blink amplifies mechanical trauma to the tarsal conjunctiva

Host-Related Risk Factors

• Atopic history: Personal or family history of atopic dermatitis, allergic rhinitis, or asthma increases susceptibility to immune sensitisation; atopic contact lens wearers develop GPC more rapidly and with greater severity
• Elevated serum IgE: Systemic atopic predisposition amplifies the IgE-mediated component of GPC
• Dry eye disease (DED): Reduced tear volume and altered tear protein composition impair the lubricating layer over the contact lens, increasing shear stress; DED co-exists with GPC in a significant proportion of patients
• Previous GPC: Sensitised conjunctiva is more vulnerable to recurrence; reintroduction of contact lenses after GPC resolution must be managed carefully
• High tear lysozyme concentration: Lysozyme-rich tear profiles are associated with greater lens protein deposition and higher GPC risk, particularly in soft hydrogel wearers
• Duration of contact lens wear: GPC incidence increases with cumulative years of lens wear; 10–30% of soft lens wearers will develop some degree of GPC over their wearing lifetime

Upper Tarsal Conjunctiva (Primary Site — Lid Eversion Required)

• Giant papillae (>1 mm): The pathognomonic finding; uniformly distributed across the superior tarsal plate producing a cobblestone or pebbled appearance; each papilla has a raised, dome-shaped profile with a central fibrovascular core visible as a red dot under magnification; surfaces may appear glistening or hyperaemic
• Conjunctival hyperaemia: Diffuse redness of the tarsal conjunctiva, most intense at the papillary surfaces; early disease may show only mild injection between papillae
• Mucoid discharge accumulation: Sticky white-grey mucoid strands adherent to papilla surfaces and the upper fornix; quantity increases with severity grade; lens contamination with mucus is a common patient complaint
• Apical epithelial stippling: Fluorescein or rose bengal staining of the flattened tips of giant papillae; indicates active mechanical abrasion of papilla epithelium by the lens posterior surface; a marker of advanced disease and active mechanical damage
• Subepithelial fibrosis: White fibrous bands visible in the substantia propria between papillae in longstanding or severe GPC; contributes to permanent structural changes if disease is inadequately treated

Eyelid Signs

• Pseudoptosis: Mechanical drooping of the upper eyelid due to the mass effect of giant papillae and associated oedema of the upper tarsal plate; distinguishable from neurogenic ptosis by lid eversion revealing the underlying papillae
• Upper lid oedema: Inflammatory oedema of the upper lid in moderate-to-severe GPC; contributes to the sense of lid heaviness reported by patients

Contact Lens and Ocular Surface Signs

• Lens surface deposits: Visible protein (white–grey irregular deposits) and lipid (greasy film or crescent deposits) on the lens anterior and posterior surfaces; jelly bumps — raised protein aggregates — are characteristic of high-water-content hydrogel lenses with lysozyme denaturation
• Excessive lens movement: Giant papillae physically displace the lens superiorly on each blink; the lens can be seen riding high or decentring upward; patients notice blurring on each blink as the lens moves off the visual axis
• Lens surface wettability loss: Deposits reduce lens wettability, creating dry patches visible as localised fluorescein pooling or non-wetting areas under slit lamp observation
• Bulbar conjunctival injection: Mild diffuse injection; less prominent than the tarsal changes; more pronounced in advanced cases with secondary dry eye or toxic reaction to care solutions
• Corneal signs: Usually absent in uncomplicated GPC; superior superficial punctate keratopathy (SPK) may occur from mucoid discharge and lens movement; frank corneal involvement (infiltrates, ulceration) is uncommon and should raise suspicion for a concurrent or alternative diagnosis

Primary Symptoms

• Itching: The cardinal symptom; typically occurring after lens removal (a distinguishing feature from allergic conjunctivitis where itch is during allergen exposure); progresses to constant pruritus in advanced disease; often described as a deep itch under the upper eyelid
• Mucoid discharge: Stringy, white to grey discharge that accumulates in the corners of the eyes and may be mistaken for mucopurulent bacterial discharge; patients report “sticky eyes” particularly in the morning
• Lens awareness and discomfort: Progressive reduction in comfortable lens wearing time; sensation of something under the upper eyelid during lens wear; patients may report that lenses which previously felt comfortable have become irritating
• Blurring of vision with lens in situ: Intermittent blurring, particularly on blinking, as giant papillae displace the lens superiorly; mucoid deposits on the lens optical zone also reduce vision clarity
• Increased lens movement: Patients are aware of the lens riding high after blinking and taking time to re-centre; this symptom directly reflects the mechanical ejection of the lens by contracting giant papillae
• Reduced wearing time: Progressive intolerance; daily wear time decreases from the patient’s usual comfortable duration; in Grade 4, lenses cannot be tolerated at all

Symptom Temporal Patterns

Contact Lens–Related Complications

• Contact lens dropout: The most functionally significant consequence; patients who cannot achieve sustained disease remission or who do not comply with management are forced to abandon lens wear permanently; loss of contact lens wear has significant quality-of-life, occupational, and refractive implications, particularly in high myopes and those requiring contact lenses for sport or work
• Progressive lens intolerance despite treatment: If GPC is inadequately treated or the provocative stimulus not modified, the inflammatory state becomes refractory and lens wear cannot be resumed even after medical therapy
• Secondary microbial keratitis risk: Excessive lens movement, compromised ocular surface integrity, and changes in blinking mechanics increase the risk of contact lens–associated microbial keratitis (CLMK), particularly with extended wear; CLMK is a sight-threatening complication

Conjunctival Complications

• Subepithelial fibrosis: Permanent fibrous scarring of the tarsal conjunctival stroma in longstanding or undertreated GPC; visible as white fibrotic bands; reduces conjunctival elasticity and may cause persistent discomfort even after disease resolution
• Goblet cell depletion: Chronic inflammatory damage to conjunctival goblet cells reduces mucin layer quality and quantity, producing secondary aqueous-deficient or evaporative dry eye that persists after GPC resolution and complicates lens wear resumption
• Tarsal conjunctival scarring: In severe or prolonged cases, the normal smooth conjunctival architecture is replaced by irregular fibrovascular tissue; this structural change is largely irreversible

Corneal Complications (Uncommon)

• Superior superficial punctate keratopathy (SPK): From mechanical abrasion by mucoid discharge and the displaced lens; usually mild and reversible
• Superior corneal pannus: In severe or longstanding GPC — particularly prosthesis-associated — superior vascularisation may extend onto the peripheral cornea; typically mild and resolves with treatment
• Shield ulcer (rare): Described in severe GPC mimicking VKC; oval epithelial defect in the superior cornea from sustained mechanical abrasion by confluent giant papillae; requires urgent ophthalmology referral

Steroid-Related Complications of Treatment

• Steroid-induced ocular hypertension and glaucoma: Risk with topical corticosteroid use; mandatory IOP monitoring every 2–4 weeks during therapy
• Posterior subcapsular cataract: Complication of prolonged topical or systemic corticosteroid therapy
• Herpetic reactivation: Topical steroids without antiviral cover may unmask latent HSV keratitis

Atopic Disease

GPC is not primarily a systemic allergic disease, but atopy significantly modulates its expression and severity. Patients with atopic dermatitis, allergic rhinitis, or asthma develop GPC more quickly after contact lens fitting, experience more severe grades, and are less likely to achieve sustained remission on lens wear continuation. Atopic individuals have a sensitised Th2 immune background that amplifies the IgE-mediated component of GPC beyond that driven by mechanical factors alone. In these patients, systemic antihistamines and allergen avoidance may modestly reduce ocular symptoms as adjuncts to local management.

Dry Eye Disease and Meibomian Gland Dysfunction

Dry eye disease (DED) and meibomian gland dysfunction (MGD) co-exist with GPC in a substantial proportion of contact lens wearers. The relationship is bidirectional: GPC-driven goblet cell depletion worsens DED, and pre-existing DED accelerates lens surface protein denaturation and reduces the lubricating film over the lens, amplifying mechanical trauma to the tarsal conjunctiva. Treating DED concurrently is essential for successful GPC management and lens wear resumption.

Systemic Conditions Relevant to Prosthesis-Associated GPC

• Enucleation / evisceration: Patients who have undergone eye removal for any cause (trauma, malignancy, painful blind eye) and are fitted with ocular prostheses carry a lifetime risk of prosthesis-induced GPC; regular prosthesis polishing, cleaning, and annual review by an ocularist and optometrist is recommended
• Retinoblastoma survivors: Paediatric patients who underwent enucleation for retinoblastoma require long-term prosthetic monitoring; GPC in children with prostheses can be difficult to detect due to limited cooperation with lid eversion
• Trauma-related prosthetics: Orbital trauma with secondary implant fitting; irregular or eroded implants accelerate tarsal mechanical damage

No Significant Systemic Inflammatory Comorbidity

Unlike atopic keratoconjunctivitis, vernal keratoconjunctivitis, or mucous membrane pemphigoid, GPC does not carry a risk of systemic inflammatory disease or involve extra-ocular organs. The condition is localised to the conjunctival surface and its pathology, while immune-mediated in part, does not predict or cause systemic autoimmune or atopic disease in the absence of a pre-existing atopic background.

Diagnostic Criteria

The diagnosis of GPC is clinical and based on the combination of: (1) a history of contact lens wear, ocular prosthesis, or exposed ocular suture; (2) characteristic symptoms of post-removal itch, mucoid discharge, and lens intolerance; and (3) slit lamp finding of giant papillae (>1 mm) on upper tarsal conjunctiva on lid eversion. No laboratory investigations are required for the diagnosis in typical cases.

History

• Type, brand, and replacement schedule of contact lenses (daily, fortnightly, monthly, reusable)
• Wearing modality (daily wear vs. extended/continuous wear)
• Lens care system: multipurpose solution type, rub-and-rinse vs. no-rub compliance, case hygiene
• Duration and onset of symptoms; temporal relationship of symptoms to lens insertion and removal
• History of atopic disease, hay fever, eczema, or asthma
• History of ocular surgery, sutures, or prosthesis use
• Previous episodes of GPC and treatments tried
• Current topical medications and preservative status

Clinical Examination

Ancillary Investigations (Selected Cases)

• Conjunctival cytology (scraping / impression cytology): Eosinophil presence on Giemsa staining supports allergic aetiology; goblet cell density assessment; useful when the differential includes VKC or AKC
• Lens surface analysis: Scanning electron microscopy and protein assays of retrieved lenses have been used in research to quantify and characterise deposits; not routine clinical tools
• Serum IgE / specific IgE (RAST): In patients with suspected atopic background where systemic management is being considered; not required for GPC diagnosis
• Conjunctival biopsy: Reserved for atypical presentations or when ruling out conjunctival malignancy (OSSN, lymphoma) in patients with conjunctival masses

Overall Prognosis

The prognosis for GPC is generally excellent when the condition is identified early and the provocative stimulus is appropriately modified or removed. Unlike atopic keratoconjunctivitis or vernal keratoconjunctivitis, GPC rarely threatens vision and does not produce permanent cicatricial changes when managed promptly. The majority of patients achieve full symptomatic resolution and are able to resume contact lens wear — in a modified form — within 3–6 months of appropriate management. However, GPC is a chronic condition with a high tendency for recurrence if lens wear habits or lens choice are not permanently modified. Patients who resume the same lens type and care regimen that precipitated the original episode have a recurrence rate exceeding 50%.

Prognostic Factors by Category

Long-Term Lens Wear Outcomes

Studies of contact lens wearers who have experienced GPC report that 60–80% can successfully resume lens wear after appropriate management when switched to daily disposable lenses, with recurrence rates of less than 20% at 1 year on daily disposables. By contrast, resumption with conventional monthly replacement lenses using multipurpose solutions carries a recurrence rate of 40–60% within the first year. Patients with Grade 4 disease, underlying atopy, or subepithelial fibrosis have lower rates of successful lens wear resumption. Scleral lenses — which vault the cornea and minimise tarsal contact — have been used successfully in refractory cases requiring lens correction for high refractive error or irregular corneas.